This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Utah Research Foundation. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Innovations of Alberto Bosque-Pardos in Anti-Retroviral Research
Introduction
Alberto Bosque-Pardos is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of anti-retroviral latency drugs, particularly in the context of HIV-1 treatment. His work focuses on innovative compounds that can potentially reactivate latent retroviruses, offering new avenues for therapeutic interventions.
Latest Patents
Alberto Bosque-Pardos holds a patent for "Trizol-1-OL analogs anti-retroviral latency drugs." This invention relates to triazol-1-ol compounds and their analogs, which can be used in compositions and methods to reactivate latent HIV-1. The patent outlines the potential applications of these compounds in diagnosing and treating retroviruses, specifically targeting HIV-1. The abstract serves as a tool for searching within the relevant field and does not limit the scope of the invention.
Career Highlights
Bosque-Pardos is affiliated with the University of Utah Research Foundation, where he continues to advance his research in anti-retroviral therapies. His work is characterized by a commitment to addressing the challenges posed by latent retroviruses, particularly in the context of HIV-1.
Collaborations
Alberto has collaborated with notable colleagues such as Ryan Van Wagoner and Vincente Planelles. These partnerships have contributed to the development and refinement of his innovative approaches to retroviral latency.
Conclusion
Alberto Bosque-Pardos is a pioneering inventor whose work in anti-retroviral latency drugs holds promise for improving treatment options for HIV-1. His contributions to the field are significant and reflect a dedication to advancing medical science.